Treatment of Non-Tuberculous Mycobacterial Lung Disease

Current Treatment Options in Infectious Diseases
Julie V PhilleyEdward D Chan

Abstract

Treatment of non-tuberculous mycobacterial lung disease (NTM-LD) is challenging for several reasons including the relative resistance of NTM to currently available drugs and the difficulty in tolerating prolonged treatment with multiple drugs. Yet-to-be-done, large, multicenter, prospective randomized studies to establish the best regimens will also be arduous because multiple NTM species are known to cause human lung disease, differences in virulence and response to treatment between different species and strains within a species will make randomization more difficult, the need to distinguish relapse from a new infection, and the difficulty in adhering to the prescribed treatment due to intolerance, toxicity, and/or drug-drug interactions, often necessitating modification of therapeutic regimens. Furthermore, the out-of-state resident status of many patients seen at the relatively few centers that care for large number of NTM-LD patients pose logistical issues in monitoring response to treatment. Thus, current treatment regimens for NTM-LD is largely based on small case series, retrospective analyses, and guidelines based on expert opinions. It has been nearly 10 years since the publication of a consensus guideline for the tre...Continue Reading

References

Jun 1, 1992·Applied and Environmental Microbiology·R Schulze-Röbbecke, K Buchholtz
Jan 1, 1992·Clinical Microbiology Reviews·L G Wayne, H A Sramek
Jan 1, 1983·The American Review of Respiratory Disease·R C BellW G Johanson
Jun 1, 1983·The Annals of Thoracic Surgery·J F MoranW C Sealy
Jun 1, 1995·Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·J KaustováS Richtrová
Nov 1, 1995·American Journal of Respiratory and Critical Care Medicine·G ValeroJ R Graybill
May 1, 1993·The American Review of Respiratory Disease·D E GriffithR J Wallace
May 1, 1993·Journal of Bacteriology·R Frothingham, K H Wilson
Jun 1, 1996·American Journal of Respiratory and Critical Care Medicine·R J WallaceD T Murphy
Jun 1, 1996·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M J BittnerL C Preheim
Sep 1, 1996·The Journal of Antimicrobial Chemotherapy·B WattG Harris
May 1, 1997·The Journal of Antimicrobial Chemotherapy·B Watt
Sep 2, 1998·The Annals of Thoracic Surgery·K G NelsonR J Wallace
Sep 3, 1999·American Journal of Respiratory and Critical Care Medicine·E TanakaF Kuze
Feb 15, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D E GriffithR J Wallace
Feb 22, 2001·Antimicrobial Agents and Chemotherapy·R J WallaceR W Wilson
Feb 5, 2002·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Yuji ShiraishiHidehiro Konno
Jan 2, 1965·British Medical Journal·J MARKS, H SCHWABACHER
Oct 15, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·David E GriffithRichard J Wallace
Jul 28, 2004·The Annals of Thoracic Surgery·Yuji ShiraishiNobumasa Takahashi
Jul 29, 2004·International Journal of Systematic and Evolutionary Microbiology·Enrico TortoliClaudio Scarparo
Mar 4, 2006·American Journal of Respiratory and Critical Care Medicine·Phung K LamAntonino Catanzaro
May 30, 2006·The Annals of Thoracic Surgery·Masazumi WatanabeKoichi Kobayashi
Jul 22, 2006·American Journal of Respiratory and Critical Care Medicine·David E GriffithRichard J Wallace
Sep 1, 2006·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Yoshihiro KobashiMikio Oka
Feb 6, 2007·American Journal of Respiratory and Critical Care Medicine·David E GriffithUNKNOWN Infectious Disease Society of America
May 18, 2007·American Journal of Respiratory and Critical Care Medicine·Kamran KhanTheodore K Marras
Jun 30, 2007·Nature Clinical Practice. Rheumatology·Jakko van IngenDick van Soolingen
Jan 2, 2008·The European Respiratory Journal·J van IngenD van Soolingen
Mar 8, 2008·Emerging Infectious Diseases·Jakko van IngenDick van Soolingen
May 1, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jakko van IngenDick van Soolingen
May 24, 2008·The Annals of Thoracic Surgery·John D MitchellMarvin Pomerantz
Jun 6, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Maeve P MurrayAdam T Hill
Sep 2, 2008·Emerging Infectious Diseases·Birgitta SchweickertAnnette Moter
Nov 18, 2008·Microbial Pathogenesis·Yoshitaka TateishiSohkichi Matsumoto
Dec 3, 2008·Microbiology·Iskandar Ben SalahMichel Drancourt

❮ Previous
Next ❯

Citations

Feb 13, 2019·Antimicrobial Agents and Chemotherapy·Elizabeth Story-RollerGyanu Lamichhane
Oct 16, 2019·Antimicrobial Agents and Chemotherapy·Seong Mi MoonByung Woo Jhun
Oct 9, 2018·Frontiers in Microbiology·Mary A De GrooteUrs A Ochsner
Mar 7, 2020·Microbiology Resource Announcements·Mitsunori YoshidaYoshihiko Hoshino
Oct 16, 2018·Frontiers in Microbiology·Elizabeth Story-RollerGyanu Lamichhane
Jun 19, 2019·American Journal of Respiratory and Critical Care Medicine·Hyun-Woo ChoiJong-Hee Shin
Dec 20, 2019·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·Kai Ling ChinArmando Acosta
Oct 7, 2017·Current Infectious Disease Reports·Arick P SabinSusan Kline
Jun 19, 2019·Journal of Medical Microbiology·Anandi MartinHector Rodriguez Villalobos
Aug 29, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ahmad MouradJason E Stout
Dec 9, 2020·Communications Biology·Hunter R BatchelderCraig A Townsend
Feb 26, 2021·Open Forum Infectious Diseases·Taylor MorrisetteMichael J Rybak
Mar 14, 2021·Immunological Reviews·Deepshikha VermaDiane J Ordway

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Current Pulmonology Reports
Shannon NovosadKevin L Winthrop
Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases
Shen-jie TangQing Zhang
Archives of Otolaryngology--head & Neck Surgery
David L MandellJoseph E Dohar
Current Opinion in Infectious Diseases
David E Griffith, Timothy R Aksamit
© 2022 Meta ULC. All rights reserved